NCT05003960View on ClinicalTrials.gov

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Autism

PHASE1RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 23, 2022

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2027

Conditions
Autism
Interventions
BIOLOGICAL

AlloRx

cultured allogeneic adult umbilical cord derived mesenchymal stem cells

Trial Locations (3)

16675

RECRUITING

Athens Beverly Hills Medical Group, Glyfada

RECRUITING

Mediterraneo Hospital Ilias 8-12, Glyfada

Unknown

RECRUITING

Medical Surgical Associates Center, St John's

All Listed Sponsors
lead

The Foundation for Orthopaedics and Regenerative Medicine

OTHER